Evidence map›Paper›PMID 23940040›Full record

ArticleThe Journal of biological chemistry2013

Link protein N-terminal peptide binds to bone morphogenetic protein (BMP) type II receptor and drives matrix protein expression in rabbit intervertebral disc cells.

Zili Wang, M Neale Weitzmann, Sreedhara Sangadala, William C Hutton, S Tim Yoon

Open access · hybridAbstract read
In one paragraph

Article in The Journal of biological chemistry, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 23 papers.

0numbers the graph read from it
0cells of the map it votes in
23citing papers in PubMed
2.3field-weighted citation impact, top 13% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

23 citing papers in PubMed, 43 citations in OpenAlex.

  1. Review
  2. Review
  3. Article
  4. Article
  5. Peptide Regulation of Chondrogenic Stem Cell Differentiation.International journal of molecular sciences · 2023
    Review
  6. Review
  7. Review
  8. Article
  9. Review
  10. Article
  11. Article
  12. Review
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 1 country.

Zili WangFrom the Atlanta Department of Veterans Affairs Medical Center, Decatur, Georgia 30033.
M Neale Weitzmann
Sreedhara Sangadala
William C Hutton
S Tim Yoon
Emory University · USUnited States Department of Veterans Affairs · US

Funding

Bone Loss and Immune Reconstitution in HIV/AIDSR01AG040013 · NIA · EMORY UNIVERSITY · PI OFOTOKUN, IGHOVWERHA, WEITZMANN, MERVYN NEALE · 2011 to 2015
$2.8M
NIA NIH HHS R01 AG040013
6 · The paper itself

Abstract

Intervertebral disc (IVD) degeneration and associated spinal disorders are leading sources of morbidity, and they can be responsible for chronic low back pain. Treatments for degenerative disc diseases continue to be a challenge. Intensive research is now focusing on promoting regeneration of degenerated discs by stimulating production of the disc matrix. Link protein N-terminal peptide (LPP) is a proteolytic fragment of link protein, an important cross-linker and stabilizer of the major structural components of cartilage, aggrecan and hyaluronan. In this study we investigated LPP action in rabbit primary intervertebral disc cells cultured ex vivo in a three-dimensional alginate matrix. Our data reveal that LPP promotes disc matrix production, which was evidenced by increased expression of the chondrocyte-specific transcription factor SOX9 and the extracellular matrix macromolecules aggrecan and collagen II. Using colocalization and pulldown studies we further document a noggin-insensitive direct peptide-protein association between LPP and BMP-RII. This association mediated Smad signaling that converges on BMP genes leading to expression of BMP-4 and BMP-7. Furthermore, through a cell-autonomous loop BMP-4 and BMP-7 intensified Smad1/5 signaling though a feedforward circuit involving BMP-RI, ultimately promoting expression of SOX9 and downstream aggrecan and collagen II genes. Our data define a complex regulatory signaling cascade initiated by LPP and suggest that LPP may be a useful therapeutic substitute for direct BMP administration to treat IVD degeneration and to ameliorate IVD-associated chronic low back pain.

Indexed as

Signal TransductionAggrecansAnimalsBone Morphogenetic Protein Receptors, Type IICarrier ProteinsChondrocytesCollagen Type IIEnzyme-Linked Immunosorbent AssayExtracellular Matrix ProteinsIntervertebral DiscNoggin ProteinPeptide FragmentsPhosphorylationProtein BindingProtein Interaction MappingProtein Structure, TertiaryAggrecansBone Morphogenetic Protein Receptors, Type IICarrier ProteinsCollagen Type IIExtracellular Matrix ProteinsNoggin ProteinPeptide FragmentsProteoglycan Link ProteinProteoglycansSOX9 Transcription FactorBMP-RIBMP-RIICell SignalingDegenerated Disc DiseaseGene RegulationIntervertebral DiscLPPPeptide InteractionsRegenerative MedicineSignal Transduction

Identifiers

PMID23940040
PMCPMC3784733
OpenAlexW2010326838

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.